| Chemically defined generation of human cardiomyocytes PW Burridge, E Matsa, P Shukla, ZC Lin, JM Churko, AD Ebert, F Lan, ... Nature methods 11 (8), 855-860, 2014 | 1609 | 2014 |
| Human induced pluripotent stem cell–derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity PW Burridge, YF Li, E Matsa, H Wu, SG Ong, A Sharma, A Holmström, ... Nature medicine 22 (5), 547-556, 2016 | 689 | 2016 |
| Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation E Matsa, D Rajamohan, E Dick, L Young, I Mellor, A Staniforth, C Denning European heart journal 32 (8), 952-962, 2011 | 464 | 2011 |
| High-throughput screening of tyrosine kinase inhibitor cardiotoxicity with human induced pluripotent stem cells A Sharma, PW Burridge, WL McKeithan, R Serrano, P Shukla, N Sayed, ... Science translational medicine 9 (377), eaaf2584, 2017 | 349 | 2017 |
| Human stem cells for modeling heart disease and for drug discovery E Matsa, PW Burridge, JC Wu Science translational medicine 6 (239), 239ps6-239ps6, 2014 | 242 | 2014 |
| Epigenetic regulation of phosphodiesterases 2A and 3A underlies compromised β-adrenergic signaling in an iPSC model of dilated cardiomyopathy H Wu, J Lee, LG Vincent, Q Wang, M Gu, F Lan, JM Churko, KI Sallam, ... Cell stem cell 17 (1), 89-100, 2015 | 192 | 2015 |
| Induced pluripotent stem cells: at the heart of cardiovascular precision medicine IY Chen, E Matsa, JC Wu Nature Reviews Cardiology 13 (6), 333-349, 2016 | 183 | 2016 |
| Transcriptome profiling of patient-specific human iPSC-cardiomyocytes predicts individual drug safety and efficacy responses in vitro E Matsa, PW Burridge, KH Yu, JH Ahrens, V Termglinchan, H Wu, C Liu, ... Cell stem cell 19 (3), 311-325, 2016 | 166 | 2016 |
| Human induced pluripotent stem cell–derived cardiomyocytes as an in vitro model for coxsackievirus B3–induced myocarditis and antiviral drug screening platform A Sharma, C Marceau, R Hamaguchi, PW Burridge, K Rajarajan, ... Circulation research 115 (6), 556-566, 2014 | 162 | 2014 |
| Passive stretch induces structural and functional maturation of engineered heart muscle as predicted by computational modeling OJ Abilez, E Tzatzalos, H Yang, MT Zhao, G Jung, AM Zöllner, M Tiburcy, ... Stem cells 36 (2), 265-277, 2018 | 144 | 2018 |
| Allele-specific RNA interference rescues the long-QT syndrome phenotype in human-induced pluripotency stem cell cardiomyocytes E Matsa, JE Dixon, C Medway, O Georgiou, MJ Patel, K Morgan, PJ Kemp, ... European heart journal 35 (16), 1078-1087, 2014 | 143 | 2014 |
| Current status of drug screening and disease modelling in human pluripotent stem cells D Rajamohan, E Matsa, S Kalra, J Crutchley, A Patel, V George, ... Bioessays 35 (3), 281-298, 2013 | 124 | 2013 |
| Feeder-free culture of human embryonic stem cells in conditioned medium for efficient genetic modification SR Braam, C Denning, E Matsa, LE Young, R Passier, CL Mummery Nature protocols 3 (9), 1435-1443, 2008 | 112 | 2008 |
| Human induced pluripotent stem cells as a platform for personalized and precision cardiovascular medicine E Matsa, JH Ahrens, JC Wu Physiological Reviews 96 (3), 1093-1126, 2016 | 107 | 2016 |
| Repolarization reserve determines drug responses in human pluripotent stem cell derived cardiomyocytes SR Braam, L Tertoolen, S Casini, E Matsa, HR Lu, A Teisman, R Passier, ... Stem cell research 10 (1), 48-56, 2013 | 85 | 2013 |
| A comprehensive TALEN-based knockout library for generating human-induced pluripotent stem cell–based models for cardiovascular diseases I Karakikes, V Termglinchan, DA Cepeda, J Lee, S Diecke, A Hendel, ... Circulation Research 120 (10), 1561-1571, 2017 | 63 | 2017 |
| Accurate nanoelectrode recording of human pluripotent stem cell-derived cardiomyocytes for assaying drugs and modeling disease ZC Lin, AF McGuire, PW Burridge, E Matsa, HY Lou, JC Wu, B Cui Microsystems & nanoengineering 3 (1), 1-7, 2017 | 62 | 2017 |
| Cardiac stem cell biology: glimpse of the past, present, and future E Matsa, K Sallam, JC Wu Circulation research 114 (1), 21-27, 2014 | 62 | 2014 |
| 5-hydroxymethyl-cytosine enrichment of non-committed cells is not a universal feature of vertebrate development RD Almeida, M Loose, V Sottile, E Matsa, C Denning, L Young, ... Epigenetics 7 (4), 383-389, 2012 | 60 | 2012 |
| Aberrant α-adrenergic hypertrophic response in cardiomyocytes from human induced pluripotent cells G Földes, E Matsa, J Kriston-Vizi, T Leja, S Amisten, L Kolker, ... Stem cell reports 3 (5), 905-914, 2014 | 53 | 2014 |
Joseph C. WuStanford University, Director, Cardiovascular Institute, Professor of Medicine & Radiology,Verified email at stanford.edu
